• LDS
  • /Medical Tests
  • /PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio

Diseases (4)
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

Overview
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

Clinical Utility
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

Interpretation
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

Reference Ranges
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

Methodology
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

Specimen Collection
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

Additional Testing
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

Turnaround Time
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

CPT
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

LOINC
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

ICD10
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

Additional ICD10
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

References
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.

Panel Test Components
Access to PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio is restricted.